Advanced search
Publication Cover
Substance Abuse Volume 35, 2014 - Issue 3
Journal homepage
2,647
Views
5
CrossRef citations to date
0
Altmetric
SPECIAL SECTION ON INTERNATIONAL ADDICTION ISSUES

Overview of Substance Use and Treatment from Australia

Paul S. HaberDrug Health Services, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia;Central Clinical School, University of Sydney, New South Wales, AustraliaView further author information
, MD &
Carolyn A. DayCentral Clinical School, University of Sydney, New South Wales, AustraliaCorrespondence[email protected]
View further author information
, PhD
Pages 304-308 | Published online: 08 Aug 2014

REFERENCES

  • Shand F, Topp L, Darke S, Makkai T, Griffiths P. The monitoring of drug trends in Australia. Drug Alcohol Rev. 2003;22:63–74.
  • Australian Institute of Health and Welfare. 2010 National Drug Strategy Household Survey Report. Canberra: Australian Institute of Health and Welfare; 2011. Drug Statistics Series No. 25. Catalogue No. PHE 145.
  • McBride O, Teesson M, Slade T, Hasin DS, Degenhardt L, Baillie A. Further evidence of differences in substance use and dependence between Australia and the United States. Drug Alcohol Depend. 2009;100:258–264.
  • Leong M, Murnion B, Haber P. Examination of opioid prescribing in Australia from 1992 to 2007. Intern Med J. 2009;39:676–681.
  • Teesson M, Slade T, Mills K. Comorbidity in Australia: findings of the 2007 National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry. 2009;43:606–614.
  • Fitzgerald JL, Sewards T. Drug Policy: The Australian Approach. Canberra: Australian National Council on Drugs; 2002. ANCD Research Paper No. 5.
  • Hall W, Carter A. Historical perspectives of drug use and ramifications for the future. In: Ritter A, King T, Hamilton M, eds. Drug Use in Australia. Melbourne: Oxford University Press; 2013:27–50.
  • Treloar C, Fraser S. Public opinion on needle and syringe programmes: avoiding assumptions for policy and practice. Drug Alcohol Rev. 2007;26:355–361.
  • Topp L, Day CA, Iversen J, Wand H, Maher L. Fifteen years of HIV surveillance among people who inject drugs: the Australian Needle and Syringe Program Survey 1995–2009 AIDS. 2011;25:835–842.
  • Iversen J, Maher L. Australian Needle and Syringe Program Survey National Data Report 2008–2013. Sydney: The Kirby Institute for Infection and Immunity in Society, The University of New South Wales; 2013.
  • National Centre in HIV Epidemiology and Clinical Research. Return on Investment 2: Evaluating the Cost-Effectivenes of Needle and Syringe Programs Among Injecting Drug Users in Australia. Sydney: National Centre in HIV Epidemiology and Clinical Research, University of New South Wales; 2009.
  • Mathers BM, Degenhardt L, Phillips B, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008; 375:1014–1028.
  • Centers for Disease Control and Prevention. HIV infection among injection-drug users, 34 states, 2004–2007. MMWR Morb Mort Wkly Rep. 2009;58:1291–1295.
  • Stafford J, Burns L. Australian Drug Trends 2012: Findings from the Illicit Drug Reporting System (IDRS). Sydney: National Drug and Alcohol Research Centre, University of New South Wales; 2013. Australian Drug Trends Series No. 91.
  • Day C, Degenhardt L, Hall W. Heroin markets in New South Wales: documenting the heroin shortage. Drug Alcohol Rev. 2006;25:293–301.
  • Breen CL, Degenhardt LJ, Bruno RB, Roxburgh AD, Jenkinson R. The effects of restricting publicly subsidised temazepam capsules on benzodiazepine use among injecting drug users in Australia. Med J Aust. 2004;181:300–304.
  • Degenhardt L, Black E, Breen C, et al. Trends in morphine prescriptions, illicit morphine use and associated harms among regular injecting drug users in Australia. Drug Alcohol Rev. 2006;25:403–412.
  • Ritter A, McLeod R, Shanahan M. Government Drug Policy Expenditure in Australia—2009/10. Sydney: National Drug and Alcohol Research Centre; 2013. Monograph No. 24.
  • Organization for Economic Co-operation and Development (OECD). OECD Annual Report 2007. Paris: OECD; 2007.
  • Stankevicius A. Consumers and copayments: implications for health and Medicare. Med J Aust 2014;200(9):517–558.
  • Vos T, Barker B, Stanley L, Lopez A. The Burden of Disease and Injury in Aboriginal and Torres Strait Islander Peoples 2003. Brisbane: University of Queensland; 2007.
  • Australian Institute of Health and Welfare. Substance Use Among Aboriginal and Torres Strait Islander People. Canberra: Australian Institute of Health and Welfare; 2011. Catalogue No. IHW 40.
  • Ministerial Advisory Council on Drugs. National Drug Strategy Aboriginal and Torres Strait Islander Peoples Complementary Action Plan 2003–2009. Canberra: Commonwealth Government of Australia; 2006.
  • Lee K, Freeburn B, Ella S, Miller W, Perry J, Conigrave KM. Handbook for Aboriginal Alcohol and Drug Work. Sydney: University of Sydney; 2012.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.